Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
milleri, stefano
nITRo, NCT03528785 / 2017-000345-46: A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer	Recruiting	2	67	Europe	Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid	Centro Ricerche Cliniche di Verona, Baxalta GmbH	Pancreatic Adenocarcinoma	11/21	11/22
LUNGVIR, NCT05597800: Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome	Not yet recruiting	2	105	Europe	Nivolumab and Ipilimumab, Opdivo and Yervoy	Universita di Verona	NSCLC Stage IV, HIV, HBV, HCV, Long COVID	12/26	03/27
NCT05027568: A Study to Assess an ATX Inhibitor (IOA-289) in Healthy Volunteers	Completed	1	40	Europe	IOA-289, Nab paclitaxel / gemcitabine	iOnctura	Healthy	09/21	09/21
NCT06300398: IAMA-6 Oral Dose Study in Healthy Adults	Recruiting	1	72	Europe	IAMA-6, Placebo	Iama Therapeutics S.r.l.	Neurodevelopmental Disorders	09/24	09/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
milleri, stefano
nITRo, NCT03528785 / 2017-000345-46: A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer	Recruiting	2	67	Europe	Irinotecan Liposomal Injection [Onivyde]; oxaliplatin, 5-FU; Levofolinic Acid	Centro Ricerche Cliniche di Verona, Baxalta GmbH	Pancreatic Adenocarcinoma	11/21	11/22
LUNGVIR, NCT05597800: Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome	Not yet recruiting	2	105	Europe	Nivolumab and Ipilimumab, Opdivo and Yervoy	Universita di Verona	NSCLC Stage IV, HIV, HBV, HCV, Long COVID	12/26	03/27
NCT05027568: A Study to Assess an ATX Inhibitor (IOA-289) in Healthy Volunteers	Completed	1	40	Europe	IOA-289, Nab paclitaxel / gemcitabine	iOnctura	Healthy	09/21	09/21
NCT06300398: IAMA-6 Oral Dose Study in Healthy Adults	Recruiting	1	72	Europe	IAMA-6, Placebo	Iama Therapeutics S.r.l.	Neurodevelopmental Disorders	09/24	09/24